Network News

Ametefgene parvec (AB-1005) manufactured at Viralgen commercial manufacturing facility with next-generation process to deliver high-purity product with greater efficiency Berlin, Germany, and Durham, N.C., USA, April 20, 2026 – AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that it has introduced its proprietary, commercially ready […]

Researchers from Heidelberg University’s Faculty of Medicine and the Technical University of Munich have investigated the genetic activity of “budding” head and neck carcinomas. In the “buds”—clusters of cells that detach from the tumor and are associated with a poor prognosis—they found a characteristic pattern of gene activity. This marker signature provides insights into the […]

BioMed X, a leading innovation hub for pharma, has officially launched its first research team at BioMed X France, marking the establishment of its presence in one of Europe’s fastest-growing life science ecosystems. The new team, Team ADB (AI-Empowered Design of Bispecific Antibodies), is based within the XSeed Labs incubator on the R&D campus of Servier in […]

MGnify Genomes offers new ways to explore microbial communities in soil, marine sediments, and the gut If you could shrink yourself to the size of a microbe, you would discover that every handful of soil and every bucket of seawater is akin to a bustling city filled with millions of microbes. Until recently, most of […]

The bioprocess experts from BioThrust Yasemin van Heuvel, Valentin von Werz and the group of Oliver Spadiut at Technische Universität Wien and the team at SimVantage released this publication on NK-92 cell manufacturing. The team collaborated to compare our ComfyCell bioreactor with a conventional pitched-blade stirred-tank bioreactor (2 L scale). While both systems supported comparable […]

On April 20, 2026, Prof. Alwin Krämer, MD, of the Heidelberg Medical Faculty at Heidelberg University, who works at the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, received the 2026 Paul Martini Prize. The prize was awarded for groundbreaking improvements in treatment for some patients with metastases from an unknown primary tumor, known […]

A novel developed biomimetic tissue substitute combines precisely tunable mechanical properties with biological functionality and is now ready for applications in medical technology. The material was developed in the »PolyKARD« project by the Fraunhofer Institute for Applied Polymer Research IAP and the NMI Natural and Medical Sciences Institute. From April 20 to 24, 2026, the […]

Not only actual chronological age, but also individual aging at the molecular level is a key factor in the development of cancer. This was discovered by scientists at the German Cancer Research Center (DKFZ) and the Saarland Cancer Registry. If the so-called “epigenetic clocks” indicate accelerated biological aging, the likelihood of a cancer diagnosis increases. […]

Nagel, A.; Hass, E.W.; Hayes, H.; Huelbes, L.; Oliveira, S.; Hardin, H.M.; Marasigan, M.; Nisenbaum, E.; Misztal, C.; Telischi, F.F.; et al. Fimepinostat Promotes Apoptosis and Decreases Cytokine Secretion in NF2-Related Human Schwannoma Cells. Int. J. Mol. Sci. 2026, 27, 2636. https://doi.org/10.3390/ijms27062636 https://www.mdpi.com/1422-0067/27/6/2636 Simple Summary This study focuses on the action of fimepinostat, a dual histone deacetylase (HDAC)/phosphosphoinositide-3 kinase […]